loading page

Ten-year survival with Heart Mate-II in situs viscerum inversus.
  • +2
  • Alessandra Francica,
  • Francesco Onorati,
  • Livio San Biagio,
  • Leonardo Gottin,
  • Giuseppe Faggian
Alessandra Francica
Integrated University Hospital of Verona

Corresponding Author:[email protected]

Author Profile
Francesco Onorati
Integrated University Hospital of Verona
Author Profile
Livio San Biagio
Integrated University Hospital of Verona
Author Profile
Leonardo Gottin
Integrated University Hospital of Verona
Author Profile
Giuseppe Faggian
Integrated University Hospital of Verona
Author Profile

Abstract

End-stage heart failure (ESHF) represents the leading cause of death for adult congenital heart disease (ACHD) and heart transplant (HT) remains the first-line treatment. Although many patients are ineligible for transplantation due to advanced comorbidities, left ventricle assist devices (LVAD) is considered a valid option. Herein we present a case of dextrocardia in situs viscerum inversus totalis (SVIT) who was implanted with LVAD HeartMate II ten years ago. To the best of our knowledge, this was the first case of dextrocardia treated with a totally intrathoracic device and he is to date the longest survivor with a HeartMate II in SVIT.